Actively Recruiting
Wearable Devices Faciliate the Management of AMI Patients
Led by RenJi Hospital · Updated on 2025-05-29
400
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters such as heart rate, sleep time, physical activity, and blood pressure will be collected and analyzed to characterize the patients and predict clinical outcomes.
CONDITIONS
Official Title
Wearable Devices Faciliate the Management of AMI Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-75 years old
- Diagnosed with STEMI or NSTEMI according to ACC/AHA guidelines
- Approximately half male and half female participants
- Underwent coronary angiography and PCI treatment
- Provided written informed consent
You will not qualify if you...
- Under 18 years old
- Pregnant or breastfeeding
- Allergic to metallic or plastic components of wearable devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital
Shanghai, China, 200127
Actively Recruiting
Research Team
Z
Zhiguo Zou, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here